Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort

Autor:	Gatto, Mariele, Saccon, Francesca, Andreoli, Laura, Bartoloni, Elena, Benvenuti, Francesco, Bortoluzzi, Alessandra, Bozzolo, Enrica, Brunetta, Enrico, Canti, Valentina, Cardinaletti, Paolo, Ceccarelli, Fulvia, Ciccia, Francesco, Conti, Fabrizio, De Marchi, Ginevra, de Paulis, Amato, De Vita, Salvatore, Emmi, Giacomo, Faggioli, Paola, Fasano, Serena, Fredi, Micaela, Gabrielli, Armando, Gasparotto, Michela, Gerli, Roberto, Gerosa, Maria, Govoni, Marcello, Gremese, Elisa, Laria, Antonella, Larosa, Maddalena, Mosca, Marta, Orsolini, Giovanni, Pazzola, Giulia, Petricca, Luca, Ramirez, Giuseppe A., Regola, Francesca, Rossi, Francesca W., Rossini, Maurizio, Salvarani, Carlo, Scarpato, Salvatore, Tani, Chiara, Tincani, Angela, Ubiali, Tania, Urban, Maria Letizia, Zen, Margherita, Doria, Andrea, Iaccarino, Luca
Zdroj:	In Journal of Autoimmunity November 2021 124
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect